Literature DB >> 11490206

Prognostic value of renal cell carcinoma nuclear grading: multivariate analysis of 333 cases.

V Ficarra1, R Righetti, G Martignoni, A D'Amico, S Pilloni, E Rubilotta, G Malossini, G Mobilio.   

Abstract

OBJECTIVE: To evaluate the independent predictive value of the nuclear grading system according to Fuhrman in relation to the disease-specific survival of patients with renal clear cell carcinoma.
MATERIAL AND METHODS: 333 patients who underwent radical nephrectomy for renal clear cell carcinoma between 1983 and 1999 were evaluated. In all patients we retrospectively studied nuclear grading, average tumor size, multifocality, pathologic stage of primary tumor, vein invasion, lymph node involvement and distant metastases. The Kaplan-Meier method was applied to evaluate disease-specific survival rates. The log rank test was used to compare survival curves and for univariate analysis. The Cox proportional hazards model was used for the multivariate analysis.
RESULTS: Histologic grade was G1 in 83 cases (25%), G2 in 117 cases (35%), G3 in 110 cases (33%) and G4 in 23 cases (7%). Our data showed that nuclear grading according to Fuhrman is related to medium tumor size (p < 0.0001), pathologic stage of cancer (p < 0.001), venous system invasion (p < 0.001), lymph node involvement (p < 0.001) and distant metastases (p < 0.001). The disease-specific survival after 5 and 10 years was 94 and 88%, respectively, in patients with G1, 86 and 75% in patients with G2, 59 and 40% in patients with G3 and 31% in patients with G4 (log rank p value < 0.0001). Multivariate analysis showed that nuclear grading by Fuhrman has a prognostic independent predictive value (hazard ratio = 1.8461, p = 0.002).
CONCLUSIONS: Nuclear grading is an important independent predictive factor of disease-specific survival in patients with renal cell carcinoma. Copyright 2001 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2001        PMID: 11490206     DOI: 10.1159/000050968

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  10 in total

Review 1.  Prognostic factors in renal cell carcinoma.

Authors:  Alessandro Volpe; Jean Jacques Patard
Journal:  World J Urol       Date:  2010-04-03       Impact factor: 4.226

2.  Association of EMMPRIN and fascin expression in renal cell carcinoma: correlation with clinicopathological parameters.

Authors:  Wen-Chiuan Tsai; Lai-Fa Sheu; Shin Nieh; Cheng-Ping Yu; Gung-Huan Sun; Yeh-Feng Lin; Ann Chen; Jong-Shiaw Jin
Journal:  World J Urol       Date:  2006-09-23       Impact factor: 4.226

3.  Prediction models for clear cell renal cell carcinoma ISUP/WHO grade: comparison between CT radiomics and conventional contrast-enhanced CT.

Authors:  Dong Han; Yong Yu; Nan Yu; Shan Dang; Hongpei Wu; Ren Jialiang; Taiping He
Journal:  Br J Radiol       Date:  2020-08-12       Impact factor: 3.039

4.  Prognostic factors and survival of renal clear cell carcinoma patients with bone metastases.

Authors:  Attila Szendroi; Elek Dinya; Magdolna Kardos; A Marcel Szász; Zsuzsanna Németh; Katalin Ats; János Kiss; Imre Antal; Imre Romics; Miklós Szendroi
Journal:  Pathol Oncol Res       Date:  2009-07-29       Impact factor: 3.201

5.  Texture analysis and machine learning algorithms accurately predict histologic grade in small (< 4 cm) clear cell renal cell carcinomas: a pilot study.

Authors:  Shawn Haji-Momenian; Zixian Lin; Bhumi Patel; Nicole Law; Adam Michalak; Anishsanjay Nayak; James Earls; Murray Loew
Journal:  Abdom Radiol (NY)       Date:  2020-03

6.  Reclassification of the Fuhrman grading system in renal cell carcinoma-does it make a difference?

Authors:  Tahir Qayyum; Peter McArdle; Clare Orange; Morag Seywright; Paul Horgan; Grenville Oades; Michael Aitchison; Joanne Edwards
Journal:  Springerplus       Date:  2013-08-10

7.  Evaluation of a seven gene mutational profile as a prognostic factor in a population-based study of clear cell renal cell carcinoma.

Authors:  Jeroen A A van de Pol; Paranita Ferronika; Helga Westers; Manon van Engeland; Martijn M Terpstra; Kim M Smits; Kim de Lange; Piet A van den Brandt; Rolf H Sijmons; Leo J Schouten; Klaas Kok
Journal:  Sci Rep       Date:  2022-04-20       Impact factor: 4.996

8.  Differential expression of prognostic proteomic markers in primary tumour, venous tumour thrombus and metastatic renal cell cancer tissue and correlation with patient outcome.

Authors:  Alexander Laird; Fiach C O'Mahony; Jyoti Nanda; Antony C P Riddick; Marie O'Donnell; David J Harrison; Grant D Stewart
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

9.  Analysis of dual energy spectral CT and pathological grading of clear cell renal cell carcinoma (ccRCC).

Authors:  Jinyan Wei; Jianhong Zhao; Xueling Zhang; Dan Wang; Wenjuan Zhang; Zhiping Wang; Junlin Zhou
Journal:  PLoS One       Date:  2018-05-01       Impact factor: 3.240

10.  Expression signature of six-snoRNA serves as novel non-invasive biomarker for diagnosis and prognosis prediction of renal clear cell carcinoma.

Authors:  Yanyun Zhao; Yuanyuan Yan; Rong Ma; Xuemei Lv; Liwen Zhang; Jinlong Wang; Wenjing Zhu; Lan Zhao; Longyang Jiang; Lin Zhao; Lijie Wen; Bo Yang; Yuzong Chen; Miao He; Mingyan Liu; Minjie Wei
Journal:  J Cell Mol Med       Date:  2020-01-14       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.